Xylem (XYL) PT Raised to $75 at Oppenheimer Following 3Q
Oppenheimer raised its price target on Xylem (NYSE: XYL) to $75.00 (from $66.00) while ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
